e-learning
resources
Paris 2018
Monday, 17.09.2018
CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD
I. Mahmutovic Persson (Malmö, Sweden), A. öRbom (Lund, Sweden), P. öNnervik (Lund, Sweden), K. Wachenfeldt (Lund, Sweden), L. Olsson (Malmö, Sweden)
Source:
International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Session:
CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Session type:
Thematic Poster
Number:
2958
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Mahmutovic Persson (Malmö, Sweden), A. öRbom (Lund, Sweden), P. öNnervik (Lund, Sweden), K. Wachenfeldt (Lund, Sweden), L. Olsson (Malmö, Sweden). Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD. 2958
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021
Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model
Source: Eur Respir J 2006; 28: Suppl. 50, 606s
Year: 2006
Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation
versus
fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006
Molecular imaging of the progression of pulmonary fibrosis using animal models of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 605s
Year: 2006
Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
Source: International Congress 2014 – ILDs 2
Year: 2014
Imaging cystic fibrosis lung disease with MRI
Source: Eur Respir Monogr 2015; 70: 188-206
Year: 2015
Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Changes in lung function in a rat model of mild emphysema
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
Morphological characteristics and mechanism of a rat model of reexpansion pulmonary edema
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018
Preclinical models and imaging biomarkers of lung injury and disease
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021
Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
LATE-BREAKING ABSTRACT: Molecular imaging with CXCR4-gallium-68-pentixafor PET correlates with GAP index and treatment effects in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Tryptase+ mast cells associate with fibrotic regions in the lungs of idiopathic pulmonary fibrosis patients; a multiplex staining approach
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept